Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraosseous vs. Intravenous Vancomycin in Total Ankle Arthroplasty
NCT06384651Phase 4Recruiting
- Sponsor
- Houston Methodist Research Institute
- Start
- Dec 2024
- Primary completion
- Apr 2027
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vancomycin in surgical site infection (SSI), sponsored by Houston Methodist Research Institute. Started Dec 2024; status: recruiting.
02
Drugs
vancomycin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT06384651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06384651.